Sara Simeoni

814 citations
42 papers · 559 indexed · h-index 15
Topics
Pelvic floor disorders treatments (8 papers)Urinary Bladder and Prostate Research (7 papers)Botulinum Toxin and Related Neurological Disorders (6 papers)
Partner nations
ItalyUnited KingdomJapan

In The Last Decade

Sara Simeoni

40 papers receiving 536 citations

Peers

Sara Simeoni
Comparison fields: 5 of 78
  • Rheumatology 175
  • Surgery 118
  • Immunology 106
  • Pathology and Forensic Medicine 93
  • Neurology 92
Replace Fabrice Michel with:
Fabrice Michel France
Tatsuya Machida Japan
Stuart A. Royal United States
Maria Stefanidou Greece
Yehuda Hiss Israel
Ta‐Jen Lee Taiwan
Henrik Nielsen Denmark
Zhe Wu Jin China
Antonina Minniti Italy
Nanette Sarioglu Germany
Sara Simeoni relative to Fabrice Michel France Fabrice Michel's profile →
Citations per field
00.5×3.5×
Fabrice Michel · 1×
Citations per year

Countries citing papers authored by Sara Simeoni

Since Specialization
Citations

This map shows the geographic impact of Sara Simeoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Simeoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Simeoni more than expected).

Fields of papers citing papers by Sara Simeoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Simeoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Simeoni. The network helps show where Sara Simeoni may publish in the future.

Co-authorship network of co-authors of Sara Simeoni

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Simeoni. A scholar is included among the top collaborators of Sara Simeoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Simeoni. Sara Simeoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 4
5 2
6 5
7 15
8 14
9 4
10 5
11 33
12 11
13 10
14 39
15 31
16 3
17 15
18 6
19 69
20 1

About Sara Simeoni

Sara Simeoni is a scholar working on Urology, Rheumatology and Neurology, having authored 42 papers that have together received 559 indexed citations. Recurring topics across this work include Pelvic floor disorders treatments (8 papers), Urinary Bladder and Prostate Research (7 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). The work is most often cited by research in Rheumatology (175 citations), Urology (59 citations) and Dermatology (54 citations). Sara Simeoni has collaborated with scholars based in Italy, United Kingdom and Japan. Frequent co-authors include Elisa Tinazzi, Claudio Lunardi, Antonio Puccetti, Roberto Corrocher, Dimitri Peterlana, Jalesh N. Panicker, Vincenzo Ficarra, Ruggero Beri, Walter Artibani and Ryuji Sakakibara. Their work appears in journals such as Neurology, The Journal of Urology and Clinical & Experimental Allergy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026